𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

✍ Scribed by E. Shmueli; N. Wigler; M. Inbar

Book ID
116427988
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
114 KB
Volume
40
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Central nervous system progression of me
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
✍ Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 2 views

Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p

Clinicopathologic characteristics and pr
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis
✍ Kadri Altundag; Melissa L. Bondy; Nadeem Q. Mirza; Shu-Wan Kau; Kristine Broglio πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Breast cancer is the second most common cause of central nervous system (CNS) metastases. Several risk factors for CNS metastases have been reported. The objective of the current study was to describe clinicopathologic characteristics and prognostic factors in breast can